https://orcid.org/0000-0002-6810-1276
References
- Aburahma MH . Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines. Drug Deliv.23(6), 1847–1867 (2016).
- Kecman S , ŠkrbićR, BadnjevicCengic Aet al. Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants. Technol. Health Care.28(3), 325–335 (2020).
- Abdel-moneum R , Abdel-RashidRS. Bile salt stabilized nanovesicles as a promising drug delivery technology: A general overview and future perspectives. J. Drug. Deliv. Sci. Tech.104057 (2022).
- Pardridge WM . blood–brain barrier delivery. Drug Discov. Today.12(1-2), 54–61 (2007).
- Ballabh P , BraunA, NedergaardM. The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis.16(1), 1–13 (2004).
- Wang C , SunJ, ChenQet al. Application of Nanotechnology-Based Products in Stroke. ACS Chem. Neurosci.14(13), 2405–15 (2023).
- Gvoic M , VukmirovicS, Al-SalamiHet al. Bile acids as novel enhancers of CNS targeting antitumor drugs: A comprehensive review. Pharm. Dev. Technol.26(6), 617–633 (2021).
- Palmela I , CorreiaL, SilvaRFet al. Hydrophilic bile acids protect human blood–brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study. Front. Neurosci.9, 80 (2015).
- Abbas H , GadHA, KhattabMA, MansourM. The Tragedy of Alzheimer's Disease: Towards Better Management via Resveratrol-Loaded Oral Bilosomes. Pharmaceutics.13(10), 1635 (2021).
- Abbas H , RefaiH, ElSayed Net al. Superparamagnetic iron oxide loaded chitosan coated bilosomes for magnetic nose to brain targeting of resveratrol. Int. J. Pharm.15, 610; 121244 (2021).
- Abbas H , El-FekyYA, Al-SawahliMMet al. Development and optimization of curcumin analog nano-bilosomes using 21.31 full factorial design for anti-tumor profiles improvement in human hepatocellular carcinoma: in-vitro evaluation, in-vivo safety assay. Drug Deliv.29(1), 714–727 (2022).
- Taweel MM , Aboul-EinienMH, KassemMA, ElkasabgyNA. Intranasal zolmitriptan-loaded bilosomes with extended nasal mucociliary transit time for direct nose to brain delivery. Pharmaceutics.13(11), 1828 (2021).
- Elsheikh MA , El-FekyYA, Al-SawahliMMet al. A Brain-Targeted Approach to Ameliorate Memory Disorders in a Sporadic Alzheimer's Disease Mouse Model via Intranasal Luteolin-Loaded Nanobilosomes. Pharmaceutics.14(3), 576 (2022).
- Wu C , XuQ, ChenX, LiuJ. Delivery luteolin with folacin-modified nanoparticle for glioma therapy. Int. J. Nanomedicine.14, 7515–31 (2019).
- Narayanan VA , SharmaA, PGM, JohnA. Bilosomes as a Potential Carrier to Enhance Cognitive Effects of Bacopa monnieri Extract on Oral Administration. J. Health Allied Sci. NU13, 421–430 (2023).